Skip to main content
Log in

Isosorbide Mononitrate a Nitric Oxide Donor: A Study of Its Efficacy and Safety as an Agent for Cervical Ripening

  • Original Article
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

Abstract

Objective

To study the efficacy and safety profile of isosorbide mononitrate (IMN) as an agent for cervical ripening.

Methodology

This study was conducted in the Department of Obstetrics and Gynecology, M Y Hospital & M G M Medical College Indore from September 2011 to February 2013. Pregnant women attending the antenatal clinics were screened for possible participation in the study after explaining the nature of the study. This study was conducted on 150 patients. An initial dose of 40 mg IMN was applied in the posterior vaginal fornix, and the same dose was repeated after 6 h. Cervical ripening was assessed by the change in Bishop Score 12 h after the initial application.

Results

In a study of 150 cases, mean maternal age was 22.2 ± 2.6 years (range 19–35 years) and mean gestational age was 40.5 ± 1.07 (range 40–42 weeks). 52 women were primigravidas, while 98 were multigravidas. The mean Bishop Score—before drug administration was 1.94 ± 1.3 (range 0–5), and mean fetal heart rate was 137 ± 6.2 bpm. The mean of Bishop scores before IMN administration was 1.94 ± 1.3, while mean of Bishop score after drug administration was 6.7 ± 2.2; mean difference was equal to 4.76. P value was equal to 0.0001. By conventional criteria, this difference is considered to be statistically significant. The mode of delivery 96 (64 %) delivered vaginally, while 54 (36 %) were delivered by Cesarean section. Mean Apgar score at 1 min was 8.2 ± 0.9 SD (range 7–10), while mean Apgar score at 5 min was 9.4 ± 0.6 (range 8–10). The only side effect noted was headache, and 30 cases (20 %) complained of headache.

Conclusion

IMN seems to be effective, safe, inexpensive, and well-tolerated agent for cervical ripening. It is cost effective and safe with minimal side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Kelly A J, Kavanagh J, Thomas J: Vaginal prostaglandin (PGE2 and PG F2a) for induction of labour at term, Cochrane Database Sys Rev 2003 CD003101, update in Cochrane Database Syst Rev.2009;(4):CD003101.

  2. Kelly A J, Tan B: Intravenous oxytocin alone for cervical ripening and induction of labour, Cochrane Database Syst. Rev.2001 CD003246 update in Cochrane Database Syst Rev. 2009;(4):CD003246

  3. Wing DA , Paul RH: A comparison of differing dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and labor induction, Am J Obstet Gynecol.1996 Jul 175(1), 158-164.

    Article  CAS  PubMed  Google Scholar 

  4. Sanchez-Ramos L, Peterson DE, Delke I, et al. : Labour induction with prostaglandin E1 misoprostol compared with dino- prostone vaginal insert: A randomized trial, Obstet Gynecol.1998, 91(3), 401-405

    Article  CAS  PubMed  Google Scholar 

  5. Nunes F., Rodrigues R. and Meirinho M.: Randomized comparison between intravaginal misoprostol and dinoprostone for induction of labor, Am. J. Obstet. Gynecol.1999 Sep; 181(3) 626-629.

    Article  CAS  PubMed  Google Scholar 

  6. Chanrachakul B., Herabutya Y., Punyavachira P.: Randomized trial of isosorbide mononitrate versus misoprostol for cervical ripening at term, Int J Gynaecol Obstet.2002 Aug, 78(2)139-145,

    Article  CAS  PubMed  Google Scholar 

  7. Ekerhovd E,Bullarbo M,Andersch B, et al. : Vaginal administration of the NO donor IMN for cervical ripening at term: A randomized controlled study. Am J Obstet Gynecol 2003 Dec;189(6);1692-7 .

    Article  CAS  PubMed  Google Scholar 

  8. Rameez MF, Goonewardene IM : Nitric Oxide donor isosorbide mononitrate for pre- induction cervical ripening at 41 weeks gestation: a randomized controlled trial. J Obstet Gynaecol Res 2007Aug; 33 (4): 452-6.

    Article  PubMed  Google Scholar 

  9. Gabriel R, Darnaud T, Chalot F, et al. Transvaginal sonography of the uterine cervix prior to labor induction. Ultrasound Obstet Gynecol 2002 Mar; 19(3); 254-7.

    Article  CAS  PubMed  Google Scholar 

  10. Bullarbo M, Norstrom A, Andersch B, et al. : Isosorbide Mononitrate induces increase cervical expression of cyclooxygenase-2, but not of cyclooxygenase – 1, at term. Eur J Obstet Gynecol Reprod Bio 2007 Feb;130(2):160-164.

    Article  CAS  Google Scholar 

  11. Thaler I, Kahana H: The effect of a nitric oxide donor on fetal heart rate patterns in patient with hypertention. Obstet Gynecol 2002 Nov; 100(5 Pt 1): 987-991.

    Article  CAS  PubMed  Google Scholar 

  12. Osman I, MacKenzie F, Norrie J, et al. The “PRIM” study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term. American Journal of Obstetrics and Gynecology 2006 Apr ,194(4) 1012-1021.

    Article  CAS  PubMed  Google Scholar 

Download references

Compliance with ethical requirements and Conflicts of interests

The research is in compliance with ethical standards. Permissions have been taken and is approved by the intitutional ethical committee. The authors have no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anupama Dave.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dave, A., Nigam, P. & Maru, L. Isosorbide Mononitrate a Nitric Oxide Donor: A Study of Its Efficacy and Safety as an Agent for Cervical Ripening. J Obstet Gynecol India 65, 162–166 (2015). https://doi.org/10.1007/s13224-014-0577-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-014-0577-5

Keywords

Navigation